SEI Investments’s Karyopharm Therapeutics KPTI Stock Holding History

SEI Investments’s Portfolio KPTI Stock Details KPTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$26.1K	Buy	21,436 +6,353	+42%	+$26K	﹤0.01%	3271
2026 Q2	$147K	Buy	+15,083	New	+$131K	﹤0.01%	3118
2024 Q3	–	Sell	-2,667	Closed	-$34.7K	–	2729
2024 Q2	$34.7K	Hold	2,667	–	–	﹤0.01%	2611
2024 Q1	$60.4K	Buy	+2,667	New	+$46.8K	﹤0.01%	2551
2021 Q3	–	Sell	-2,054	Closed	-$314K	–	2599
2021 Q2	$314K	Sell	2,054 -166	-7%	-$24.1K	﹤0.01%	2293
2021 Q1	$350K	Sell	2,220 -94	-4%	-$19.8K	﹤0.01%	2189
2020 Q4	$532K	Sell	2,314 -45	-2%	-$10.4K	﹤0.01%	1948
2020 Q3	$515K	Sell	2,359 -76	-3%	-$18.6K	﹤0.01%	1880
2020 Q2	$691K	Sell	2,435 -1,335	-35%	-$395K	﹤0.01%	1717
2020 Q1	$1.08M	Buy	3,770 +572	+18%	+$158K	﹤0.01%	1430
2019 Q4	$919K	Buy	3,198 +2,033	+175%	+$441K	﹤0.01%	1673
2019 Q3	$168K	Buy	+1,165	New	+$158K	﹤0.01%	2267

Other funds holding KPTI

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Context Capital Management Lajolla, California $4.89B AUM 1.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

BCM

BML Capital Management Zionsville, Indiana $188M AUM 88.51% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

SEI Investments's KPTI Position: Q3 2026 in Review

SEI Investments increased its Karyopharm Therapeutics (KPTI) stake by 42% in Q3 2026, buying an estimated $26K and bringing the position to 21,436 shares worth $26.1K. The position accounts for ﹤0.01% of the portfolio, ranked #3271.

SEI Investments first reported a position in KPTI in Q3 2019 and has held it in 12 quarters since. The position peaked at $1.08M in Q1 2020. 39 funds tracked by Wall St. Rank hold KPTI as of Q3 2026.

SEI Investments held 21,436 shares of Karyopharm Therapeutics worth $26.1K as of Q3 2026.
SEI Investments bought 6,353 Karyopharm Therapeutics shares in Q3 2026, an estimated $26K.
Karyopharm Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q3 2026, its #3271 holding.
SEI Investments first reported a position in Karyopharm Therapeutics in Q3 2019 and has held it in 12 quarters since.
SEI Investments's Karyopharm Therapeutics position peaked at $1.08M in Q1 2020.
39 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q3 2026.

Based on SEI Investments's 13F filing for Q3 2026, filed 10 Nov 2026.